• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Notch 配体 Jagged2 通过 miR-200 依赖途径促进小鼠肺腺癌转移。

The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice.

机构信息

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

出版信息

J Clin Invest. 2011 Apr;121(4):1373-85. doi: 10.1172/JCI42579. Epub 2011 Mar 14.

DOI:10.1172/JCI42579
PMID:21403400
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3069760/
Abstract

Epithelial tumor cells transit to a mesenchymal state in response to extracellular cues, in a process known as epithelial-to-mesenchymal transition (EMT). The precise nature of these cues has not been fully defined, an important issue given that EMT is an early event in tumor metastasis. Here, we have found that a population of metastasis-prone mouse lung adenocarcinoma cells expresses Notch and Notch ligands and that the Notch ligand Jagged2 promotes metastasis. Mechanistically, Jagged2 was found to promote metastasis by increasing the expression of GATA-binding (Gata) factors, which suppressed expression of the microRNA-200 (miR-200) family of microRNAs that target the transcriptional repressors that drive EMT and thereby induced EMT. Reciprocally, miR-200 inhibited expression of Gata3, which reversed EMT and abrogated metastasis, suggesting that Gata3 and miR-200 are mutually inhibitory and have opposing effects on EMT and metastasis. Consistent with this, high levels of Gata3 expression correlated with EMT in primary tumors from 2 cohorts of lung adenocarcinoma patients. These findings reveal what we believe to be a novel Jagged2/miR-200-dependent pathway that mediates lung adenocarcinoma EMT and metastasis in mice and may have implications for the treatment of human epithelial tumors.

摘要

上皮肿瘤细胞在受到细胞外信号刺激时会发生上皮-间质转化(EMT),从上皮细胞表型转变成间充质细胞表型。这些信号的精确性质尚未完全确定,这是一个重要的问题,因为 EMT 是肿瘤转移的早期事件。在这里,我们发现一群易转移的小鼠肺腺癌细胞表达 Notch 和 Notch 配体,并且 Notch 配体 Jagged2 促进转移。从机制上讲,Jagged2 通过增加 GATA 结合(Gata)因子的表达来促进转移,Gata 因子抑制了驱动 EMT 的转录抑制因子的表达,从而诱导 EMT。反过来,miR-200 抑制了 Gata3 的表达,逆转了 EMT 并阻断了转移,这表明 Gata3 和 miR-200 是相互抑制的,对 EMT 和转移有相反的影响。与此一致的是,来自两个肺腺癌患者队列的原发性肿瘤中高水平的 Gata3 表达与 EMT 相关。这些发现揭示了我们认为的一种新的 Jagged2/miR-200 依赖途径,该途径介导了小鼠肺腺癌的 EMT 和转移,可能对人类上皮肿瘤的治疗具有意义。

相似文献

1
The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice.Notch 配体 Jagged2 通过 miR-200 依赖途径促进小鼠肺腺癌转移。
J Clin Invest. 2011 Apr;121(4):1373-85. doi: 10.1172/JCI42579. Epub 2011 Mar 14.
2
microRNA-214 promotes epithelial-mesenchymal transition and metastasis in lung adenocarcinoma by targeting the suppressor-of-fused protein (Sufu).微小RNA-214通过靶向融合抑制蛋白(Sufu)促进肺腺癌上皮-间质转化和转移。
Oncotarget. 2015 Nov 17;6(36):38705-18. doi: 10.18632/oncotarget.5478.
3
MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells.MiR-134/487b/655簇通过靶向肺癌腺癌细胞中的MAGI2来调节转化生长因子-β诱导的上皮-间质转化和对吉非替尼的耐药性。
Mol Cancer Ther. 2014 Feb;13(2):444-53. doi: 10.1158/1535-7163.MCT-13-0448. Epub 2013 Nov 20.
4
Hypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells.缺氧诱导的 microRNA-34a 下调通过靶向管状上皮细胞中的 Notch 信号通路促进 EMT。
PLoS One. 2012;7(2):e30771. doi: 10.1371/journal.pone.0030771. Epub 2012 Feb 17.
5
Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer.肿瘤抑制因子 miR-200 在癌症上皮间质转化中的调控作用靶点。
Cancer Res. 2011 Dec 15;71(24):7670-82. doi: 10.1158/0008-5472.CAN-11-0964. Epub 2011 Oct 10.
6
miR-483-5p promotes invasion and metastasis of lung adenocarcinoma by targeting RhoGDI1 and ALCAM.miR-483-5p 通过靶向 RhoGDI1 和 ALCAM 促进肺腺癌的侵袭和转移。
Cancer Res. 2014 Jun 1;74(11):3031-42. doi: 10.1158/0008-5472.CAN-13-2193. Epub 2014 Apr 7.
7
TWIST1 upregulates miR-214 to promote epithelial-to-mesenchymal transition and metastasis in lung adenocarcinoma.TWIST1 通过上调 miR-214 促进肺腺癌的上皮间质转化和转移。
Int J Mol Med. 2018 Jul;42(1):461-470. doi: 10.3892/ijmm.2018.3630. Epub 2018 Apr 17.
8
The NOTCH ligand JAGGED2 promotes pancreatic cancer metastasis independent of NOTCH signaling activation.NOTCH配体JAGGED2可促进胰腺癌转移,且与NOTCH信号激活无关。
Mol Cancer Ther. 2015 Jan;14(1):289-97. doi: 10.1158/1535-7163.MCT-14-0501. Epub 2014 Oct 28.
9
miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.微小RNA-206通过靶向间质表皮转化因子(MET)部分调节人肺腺癌细胞中的顺铂耐药性和上皮-间质转化。
Oncotarget. 2016 Apr 26;7(17):24510-26. doi: 10.18632/oncotarget.8229.
10
MicroRNA-455-3p mediates GATA3 tumor suppression in mammary epithelial cells by inhibiting TGF-β signaling.miRNA-455-3p 通过抑制 TGF-β 信号通路介导 GATA3 在乳腺上皮细胞中的抑瘤作用。
J Biol Chem. 2019 Oct 25;294(43):15808-15825. doi: 10.1074/jbc.RA119.010800. Epub 2019 Sep 6.

引用本文的文献

1
Identifying New Loci and Genes Associated with Feed Efficiency in Broilers.鉴定与肉鸡饲料效率相关的新基因座和基因
Int J Mol Sci. 2025 Sep 1;26(17):8492. doi: 10.3390/ijms26178492.
2
Regulation of lung cancer initiation and progression by the stem cell determinant Musashi.干细胞决定因子Musashi对肺癌起始和进展的调控
Elife. 2025 Mar 6;13:RP97021. doi: 10.7554/eLife.97021.
3
Targeting epithelial-mesenchymal transition signaling pathways with Dietary Phytocompounds and repurposed drug combinations for overcoming drug resistance in various cancers.利用膳食植物化合物和重新利用的药物组合靶向上皮-间质转化信号通路以克服各种癌症中的耐药性。
Heliyon. 2025 Jan 23;11(3):e41964. doi: 10.1016/j.heliyon.2025.e41964. eCollection 2025 Feb 15.
4
Epithelial-mesenchymal transition in asthma: its role and underlying regulatory mechanisms.哮喘中的上皮-间质转化:其作用及潜在调控机制
Front Immunol. 2025 Jan 22;16:1519998. doi: 10.3389/fimmu.2025.1519998. eCollection 2025.
5
Broadening horizons: molecular mechanisms and disease implications of endothelial-to-mesenchymal transition.拓展视野:内皮-间充质转化的分子机制及疾病影响
Cell Commun Signal. 2025 Jan 9;23(1):16. doi: 10.1186/s12964-025-02028-y.
6
Overexpression of miR-328-3p Inhibits Epithelial-Mesenchymal Transition in Prostate Cancer by Downregulating PFN1.miR-328-3p的过表达通过下调PFN1抑制前列腺癌的上皮-间质转化
Appl Biochem Biotechnol. 2025 Apr;197(4):2240-2257. doi: 10.1007/s12010-024-05103-1. Epub 2024 Dec 24.
7
Epithelial-mesenchymal plasticity (EMP) in wound healing: Exploring EMT mechanisms, regulatory network, and therapeutic opportunities.伤口愈合中的上皮-间质可塑性(EMP):探索上皮-间质转化机制、调控网络及治疗机遇。
Heliyon. 2024 Jul 8;10(14):e34269. doi: 10.1016/j.heliyon.2024.e34269. eCollection 2024 Jul 30.
8
miR-200-mediated inactivation of cancer-associated fibroblasts via targeting of NRP2-VEGFR signaling attenuates lung cancer invasion and metastasis.通过靶向NRP2-VEGFR信号通路,miR-200介导的癌症相关成纤维细胞失活可减弱肺癌的侵袭和转移。
Mol Ther Nucleic Acids. 2024 Apr 23;35(2):102194. doi: 10.1016/j.omtn.2024.102194. eCollection 2024 Jun 11.
9
Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance.肿瘤细胞可塑性:从细胞、分子和遗传机制到肿瘤异质性和耐药性。
Cancer Metastasis Rev. 2024 Mar;43(1):197-228. doi: 10.1007/s10555-024-10172-z. Epub 2024 Feb 8.
10
MiRNAs in Lung Adenocarcinoma: Role, Diagnosis, Prognosis, and Therapy.肺腺癌中的 miRNAs:作用、诊断、预后和治疗。
Int J Mol Sci. 2023 Aug 27;24(17):13302. doi: 10.3390/ijms241713302.

本文引用的文献

1
GATA factor switching during erythroid differentiation.GATA 因子在红细胞分化过程中的转换。
Curr Opin Hematol. 2010 May;17(3):163-8. doi: 10.1097/MOH.0b013e32833800b8.
2
Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.评估可能预测局部 I 期非小细胞肺癌手术后复发的 microRNA 表达谱。
Cancer Res. 2010 Jan 1;70(1):36-45. doi: 10.1158/0008-5472.CAN-09-3153. Epub 2009 Dec 22.
3
Alterations of the Notch pathway in lung cancer.肺癌中 Notch 通路的改变。
Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22293-8. doi: 10.1073/pnas.0907781106. Epub 2009 Dec 10.
4
The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs.EMT激活因子ZEB1通过抑制抑制干性的微小RNA来促进肿瘤发生。
Nat Cell Biol. 2009 Dec;11(12):1487-95. doi: 10.1038/ncb1998. Epub 2009 Nov 22.
5
Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.高致瘤性肺癌CD133+细胞表现出干细胞样特征,并且不受顺铂治疗的影响。
Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16281-6. doi: 10.1073/pnas.0905653106. Epub 2009 Sep 10.
6
Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression.细胞外环境线索通过调节miR-200家族的表达促进肿瘤细胞的上皮-间质转化和转移。
Genes Dev. 2009 Sep 15;23(18):2140-51. doi: 10.1101/gad.1820209.
7
DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency.DLL4阻断可抑制肿瘤生长并降低肿瘤起始细胞频率。
Cell Stem Cell. 2009 Aug 7;5(2):168-77. doi: 10.1016/j.stem.2009.05.019.
8
An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors.肺癌的综合基因组分析揭示了EGFR突变肿瘤中双特异性磷酸酶4(DUSP4)的缺失。
Oncogene. 2009 Aug 6;28(31):2773-83. doi: 10.1038/onc.2009.135. Epub 2009 Jun 15.
9
Relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis.肺腺癌中与复发相关的分子特征可识别预后不良的患者。
J Clin Oncol. 2009 Jun 10;27(17):2793-9. doi: 10.1200/JCO.2008.19.7053. Epub 2009 May 4.
10
CDK inhibitor p18(INK4c) is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesis.细胞周期蛋白依赖性激酶抑制剂p18(INK4c)是GATA3的下游靶点,可抑制乳腺管腔祖细胞增殖和肿瘤发生。
Cancer Cell. 2009 May 5;15(5):389-401. doi: 10.1016/j.ccr.2009.03.004.